ACXP · Company research
Acurx Pharmaceuticals, Inc. (ACXP): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Acurx Pharmaceuticals, Inc. (ACXP) Stock Price, News, Quote & History - Yahoo! Finance Canada | Acurx Pharmaceuticals, Inc. (ACXP) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 6, 2026 | neutral | 0 | 0.6 |
| C. diff is associated with about 30,000 U.S. deaths a year. A trial for repeat infections has enrolled its first patient. - Stock Titan | C. diff is associated with about 30,000 U.S. deaths a year. A trial for repeat infections has enrolled its first patient. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Acurx Pharmaceuticals (ACXP) Slips 4.32% to $1.33, Drifting Toward Lower Support - Point of Control - https://www.siam.in/ | Acurx Pharmaceuticals (ACXP) Slips 4.32% to $1.33, Drifting Toward Lower Support - Point of Control https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Sep 21, 2026 | neutral | 0 | 0.6 |
| Acurx Pharmaceuticals, Inc. (ACXP) Stock Price & News - Syfe | Acurx Pharmaceuticals, Inc. (ACXP) Stock Price & News Syfe | View source ↗ | Syfe | Sep 9, 2026 | neutral | 0 | 0.6 |
| Acurx Pharmaceuticals, Inc. SEC Filing (Sep 1, 2026) - Stock Titan | Acurx Pharmaceuticals, Inc. SEC Filing (Sep 1, 2026) Stock Titan | View source ↗ | Stock Titan | Sep 1, 2026 | neutral | 0 | 0.6 |
| Acurx (ACXP) Price-Move Recap: Ends Down by 12.73% at $1.44 in the Latest Reading; Key Levels - dars.gov.et | Acurx (ACXP) Price-Move Recap: Ends Down by 12.73% at $1.44 in the Latest Reading; Key Levels dars.gov.et | View source ↗ | dars.gov.et | Aug 18, 2026 | neutral | 0 | 0.6 |
| Analysts Are Bullish on Top Healthcare Stocks: Candel Therapeutics (CADL), Acurx Pharmaceuticals (ACXP) - The Globe and Mail | Analysts Are Bullish on Top Healthcare Stocks: Candel Therapeutics (CADL), Acurx Pharmaceuticals (ACXP) The Globe and Mail | View source ↗ | The Globe and Mail | Aug 15, 2026 | neutral | 0 | 0.6 |
| Acurx and Leiden Researchers Seek 3D Structure to Guide MRSA Antibiotics - Stock Titan | Acurx and Leiden Researchers Seek 3D Structure to Guide MRSA Antibiotics Stock Titan | View source ↗ | Stock Titan | Aug 10, 2026 | neutral | 0 | 0.6 |
| ACXP Forecast — Price Target — Prediction for 2027 - TradingView | ACXP Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's Why - Yahoo Finance | Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's Why Yahoo Finance | View source ↗ | Yahoo Finance | Jun 8, 2026 | neutral | 0 | 0.6 |
| ACURX PHARMACEUTICALS ($ACXP) Releases Q1 2026 Earnings | ACXP Stock News - Quiver Quantitative | ACURX PHARMACEUTICALS ($ACXP) Releases Q1 2026 Earnings | ACXP Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | May 12, 2026 | neutral | 0 | 0.6 |
| Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance | Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Apr 2, 2026 | neutral | 0 | 0.6 |
| Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect? - March 19, 2026 - Zacks Investment Research | Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect? - March 19, 2026 Zacks Investment Research | View source ↗ | Zacks Investment Research | Mar 19, 2026 | neutral | 0 | 0.6 |
| Acurx Pharmaceuticals Drives Stock Surge with Major Clinical Developments - StocksToTrade | Acurx Pharmaceuticals Drives Stock Surge with Major Clinical Developments StocksToTrade | View source ↗ | StocksToTrade | Mar 17, 2026 | neutral | 0 | 0.6 |
| Acurx Pharma Stock Dips 9% Amid Market Volatility - timothysykes.com | Acurx Pharma Stock Dips 9% Amid Market Volatility timothysykes.com | View source ↗ | timothysykes.com | Mar 13, 2026 | neutral | 0 | 0.6 |
| Acurx Launches Revolutionary Trials for C. difficile Drug - Timothy Sykes | Acurx Launches Revolutionary Trials for C. difficile Drug Timothy Sykes | View source ↗ | Timothy Sykes | Mar 11, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 23, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.